Literature DB >> 1026540

Treatment with methenamine hippurate in the patient with a catheter.

K Norrman, L Wibell.   

Abstract

Methenamine hippurate, 1 g twice daily, was given for four months to twenty-two elderly female subjects with an indwelling catheter. The incidence of catheter blockage was significantly reduced when compared with the control period of similar duration, although bacteriuria persisted throughout treatment. The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026540     DOI: 10.1177/030006057600400206

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

1.  Effect of short-term high-dose treatment with methenamine hippurate on urinary infection in geriatric patients with an indwelling catheter. IV. Clinical evaluation.

Authors:  B Norberg; A Norberg; U Parkhede; H Gippert
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

2.  Randomized double-blind study of prophylactic methenamine hippurate treatment of patients with indwelling catheters.

Authors:  A Norberg; B Norberg; U Parkhede; H Gippert; K Lundbeck
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 3.  Evaluation of methenamine for urinary tract infection prevention in older adults: a review of the evidence.

Authors:  Amy Chwa; Kevin Kavanagh; Sunny Anne Linnebur; Danielle R Fixen
Journal:  Ther Adv Drug Saf       Date:  2019-09-23

Review 4.  Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects.

Authors:  Glenn T Werneburg
Journal:  Res Rep Urol       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.